Nagoya, Japan

Junki Takamatsu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nagoya University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junki Takamatsu. Retrieved from https://idiyas.com/inventor/junki-takamatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junki Takamatsu: Innovator in Pharmaceutical Composition

Introduction

Junki Takamatsu is a notable inventor based in Nagoya, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of blood clotting disorders. Her innovative work has the potential to improve patient outcomes and reduce the burden associated with these medical conditions.

Latest Patents

Junki Takamatsu holds a patent for a pharmaceutical composition aimed at the prevention or treatment of blood clotting disorders. This composition includes an effective amount of ribavirin or a derivative thereof, or a pharmaceutically acceptable salt of ribavirin or the derivative. This invention is crucial as it addresses a significant medical need and offers a new approach to treatment.

Career Highlights

Takamatsu is affiliated with Nagoya University, where she conducts her research and development activities. Her work at the university has allowed her to explore innovative solutions in the pharmaceutical field, contributing to advancements in medical science.

Collaborations

Junki Takamatsu collaborates with esteemed colleagues such as Takashi Honda and Hidenori Toyoda. These partnerships enhance her research efforts and foster a collaborative environment for innovation.

Conclusion

Junki Takamatsu's contributions to pharmaceutical compositions demonstrate her commitment to improving healthcare solutions. Her innovative patent reflects her dedication to addressing critical medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…